H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other… Read more
H&R GmbH & Co. KGaA (2HRA) - Net Assets
Latest net assets as of September 2025: €452.10 Million EUR
Based on the latest financial reports, H&R GmbH & Co. KGaA (2HRA) has net assets worth €452.10 Million EUR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€983.64 Million) and total liabilities (€531.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €452.10 Million |
| % of Total Assets | 45.96% |
| Annual Growth Rate | 9.12% |
| 5-Year Change | 35.08% |
| 10-Year Change | 63.2% |
| Growth Volatility | 17.36 |
H&R GmbH & Co. KGaA - Net Assets Trend (2002–2024)
This chart illustrates how H&R GmbH & Co. KGaA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for H&R GmbH & Co. KGaA (2002–2024)
The table below shows the annual net assets of H&R GmbH & Co. KGaA from 2002 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €468.58 Million | +2.40% |
| 2023-12-31 | €457.62 Million | -2.88% |
| 2022-12-31 | €471.16 Million | +15.35% |
| 2021-12-31 | €408.48 Million | +17.76% |
| 2020-12-31 | €346.88 Million | -4.56% |
| 2019-12-31 | €363.45 Million | +1.70% |
| 2018-12-31 | €357.37 Million | +4.27% |
| 2017-12-31 | €342.74 Million | +7.99% |
| 2016-12-31 | €317.40 Million | +10.54% |
| 2015-12-31 | €287.13 Million | +15.36% |
| 2014-12-31 | €248.90 Million | +31.58% |
| 2013-12-31 | €189.16 Million | -14.95% |
| 2012-12-31 | €222.42 Million | -7.76% |
| 2011-12-31 | €241.14 Million | +6.49% |
| 2010-12-31 | €226.44 Million | +24.64% |
| 2009-12-31 | €181.68 Million | +9.85% |
| 2008-12-31 | €165.39 Million | +0.49% |
| 2007-12-31 | €164.58 Million | +44.75% |
| 2006-12-31 | €113.70 Million | +58.27% |
| 2005-12-31 | €71.84 Million | -14.81% |
| 2004-12-31 | €84.33 Million | +3.95% |
| 2003-12-31 | €81.12 Million | +18.05% |
| 2002-12-31 | €68.72 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to H&R GmbH & Co. KGaA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1518.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €283.77 Million | 66.48% |
| Common Stock | €95.16 Million | 22.29% |
| Other Comprehensive Income | €-11.63 Million | -2.72% |
| Other Components | €59.56 Million | 13.95% |
| Total Equity | €426.86 Million | 100.00% |
H&R GmbH & Co. KGaA Competitors by Market Cap
The table below lists competitors of H&R GmbH & Co. KGaA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Lument Finance Trust Inc
NYSE:LFT
|
$34.82 Million |
|
KLEA HOLDING
PA:ALKLH
|
$34.83 Million |
|
Sernova Biotherapeutics Inc
XETRA:PSH0
|
$34.83 Million |
|
Ardea Resources Limited
PINK:ARRRF
|
$34.83 Million |
|
CastleNet Technology
TWO:8059
|
$34.80 Million |
|
Kezar Life Sciences Inc
NASDAQ:KZR
|
$34.80 Million |
|
TECH.OLYMPIC NA EO 5
F:TQZA
|
$34.79 Million |
|
Commercial National Financial Corporation
PINK:CEFC
|
$34.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in H&R GmbH & Co. KGaA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 413,017,000 to 426,861,000, a change of 13,844,000 (3.4%).
- Net income of 10,623,000 contributed positively to equity growth.
- Dividend payments of 3,722,000 reduced retained earnings.
- Other comprehensive income increased equity by 6,943,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €10.62 Million | +2.49% |
| Dividends Paid | €3.72 Million | -0.87% |
| Other Comprehensive Income | €6.94 Million | +1.63% |
| Total Change | €- | 3.35% |
Book Value vs Market Value Analysis
This analysis compares H&R GmbH & Co. KGaA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.37x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.65x to 0.37x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €2.53 | €4.19 | x |
| 2003-12-31 | €2.87 | €4.19 | x |
| 2004-12-31 | €2.83 | €4.19 | x |
| 2005-12-31 | €2.65 | €4.19 | x |
| 2006-12-31 | €4.21 | €4.19 | x |
| 2007-12-31 | €5.35 | €4.19 | x |
| 2008-12-31 | €5.37 | €4.19 | x |
| 2009-12-31 | €5.93 | €4.19 | x |
| 2010-12-31 | €7.41 | €4.19 | x |
| 2011-12-31 | €7.89 | €4.19 | x |
| 2012-12-31 | €7.28 | €4.19 | x |
| 2013-12-31 | €6.19 | €4.19 | x |
| 2014-12-31 | €6.50 | €4.19 | x |
| 2015-12-31 | €6.70 | €4.19 | x |
| 2016-12-31 | €7.55 | €4.19 | x |
| 2017-12-31 | €8.37 | €4.19 | x |
| 2018-12-31 | €8.68 | €4.19 | x |
| 2019-12-31 | €8.72 | €4.19 | x |
| 2020-12-31 | €8.26 | €4.19 | x |
| 2021-12-31 | €9.74 | €4.19 | x |
| 2022-12-31 | €11.38 | €4.19 | x |
| 2023-12-31 | €11.10 | €4.19 | x |
| 2024-12-31 | €11.47 | €4.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently H&R GmbH & Co. KGaA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.79%
- • Asset Turnover: 1.32x
- • Equity Multiplier: 2.38x
- Recent ROE (2.49%) is below the historical average (9.39%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 6.43% | 2.31% | 1.43x | 1.95x | €-2.45 Million |
| 2003 | 7.44% | 2.76% | 1.26x | 2.13x | €-1.99 Million |
| 2004 | 9.80% | 1.51% | 1.51x | 4.30x | €-154.10K |
| 2006 | 38.06% | 5.30% | 1.99x | 3.61x | €31.90 Million |
| 2007 | 31.79% | 6.52% | 2.00x | 2.43x | €35.65 Million |
| 2008 | 7.17% | 1.14% | 2.39x | 2.63x | €-4.65 Million |
| 2009 | 13.82% | 3.29% | 1.65x | 2.55x | €6.93 Million |
| 2010 | 22.97% | 4.92% | 1.99x | 2.35x | €29.38 Million |
| 2011 | 15.95% | 3.18% | 1.90x | 2.63x | €14.36 Million |
| 2012 | 0.21% | 0.04% | 1.98x | 2.79x | €-21.79 Million |
| 2013 | -7.41% | -1.16% | 2.04x | 3.14x | €-32.95 Million |
| 2014 | -7.37% | -1.45% | 1.50x | 3.38x | €-36.31 Million |
| 2015 | 10.99% | 2.74% | 1.56x | 2.57x | €2.42 Million |
| 2016 | 13.91% | 4.07% | 1.45x | 2.35x | €10.79 Million |
| 2017 | 10.51% | 3.13% | 1.55x | 2.17x | €1.56 Million |
| 2018 | 6.75% | 1.94% | 1.53x | 2.28x | €-10.41 Million |
| 2019 | -0.42% | -0.13% | 1.28x | 2.59x | €-33.81 Million |
| 2020 | -2.93% | -1.03% | 1.17x | 2.42x | €-39.78 Million |
| 2021 | 13.84% | 4.22% | 1.36x | 2.41x | €13.92 Million |
| 2022 | 10.08% | 2.71% | 1.64x | 2.27x | €345.90K |
| 2023 | 2.56% | 0.78% | 1.50x | 2.19x | €-30.75 Million |
| 2024 | 2.49% | 0.79% | 1.32x | 2.38x | €-32.06 Million |
Industry Comparison
This section compares H&R GmbH & Co. KGaA's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $24,676,081,043
- Average return on equity (ROE) among peers: -10.53%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| H&R GmbH & Co. KGaA (2HRA) | €452.10 Million | 6.43% | 1.18x | $34.81 Million |
| Kureha Corporation (0K1) | $211.14 Billion | 3.69% | 0.64x | $845.56 Million |
| Polwax S.A (1LW) | $62.24 Million | -36.57% | 0.81x | $3.52 Million |
| Renaissance Oil Corp (2R7) | $2.68 Billion | 6.64% | 1.08x | $1.32 Billion |
| Global New Material International Holdings Limited (69Y) | $2.34 Billion | 6.92% | 0.11x | $625.83 Million |
| Altech Chemicals Ltd (A3Y) | $20.44 Million | -57.36% | 0.80x | $18.88 Million |
| Beijing Media Corporation Limited (BME) | $1.33 Billion | 1.53% | 0.21x | $2.12 Million |
| BRAIN Biotech AG (BNN) | $12.12 Million | -45.67% | 0.63x | $40.90 Million |
| Brenntag SE (BNR) | $4.00 Billion | 11.22% | 1.55x | $5.76 Billion |
| CropEnergies AG (CE2) | $502.88 Million | 14.82% | 0.33x | $71.38 Million |